Noventia Pharma established in 2009, is a Specialty Pharma Company, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. It has its Headquarters in Lausanne, Switzerland, with operations in the main Southern European Countries: Italy, Greece, Spain and Portugal, and a growing presence in the new markets of Central and Eastern Europe.

The Company offers a product portfolio of innovative pharmaceuticals, both proprietary and under license, in a different number of therapeutic areas including a specialized business dedicated to treatments of Rare and Neglected Diseases.

Noventia Pharma  is committed to the research and development of new drug entities, with a particular focus on Orphan Drugs for the treatments of  Rare Diseases, in particular in the CNS therapeutic area, as well as for Neglected Diseases.